Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice.

In the Beam Walking test, rhNGF treatment abolished the motor defect affecting untreated HET mice, leading to an almost significant rescue ( Fig. 5E ).

also in 996 other papers